IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
SARS-CoV-2에 대한 IL-33 발현은 COVID-19 회복기 개인의 혈청 양성과 상관관계가 있습니다
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adults
age
anti-SARS-CoV-2 antibody
anti-Spike IgG
Antibody titer
Asthma
BALF
Bronchoalveolar lavage fluid
CD14
CD4
Cell
cells
chronic disease
Chronic diseases
Cohort
convalescent
convalescent individual
convalescent individuals
COPD
coronavirus
COVID-19
COVID-19 pathogenesis
days post-infection
disease severity
Effect
elicit
Epidemiology
expression
Fever
glycoprotein
IFNA2
IL-1β
IL-23
IL-33
IL-6
immune
immune response
immune responses
Immunity
increase
Infection
Interleukins
Mild
Monocytes
observational study
Pathogenesis
Patient
PBMC
PBMCs
PCR
peptide
produced
Pulmonary infection
recall
reveal
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike glycoprotein
scRNAseq
seronegative
seropositive
seropositive individuals
Seropositivity
Seropositivity for SARS-CoV-2
Seroprevalence
severe acute respiratory syndrome Coronavirus
severe COVID-19
spike
spike glycoprotein
spike IgG
subject
subset
Symptoms
T cell
T cell activation
the disease
their family member
their family members
TLR7
TNF
virus
[DOI] 10.1038/s41467-021-22449-w PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-021-22449-w PMC 바로가기 [Article Type] Article